BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17436255)

  • 1. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).
    Zweier C; Peippo MM; Hoyer J; Sousa S; Bottani A; Clayton-Smith J; Reardon W; Saraiva J; Cabral A; Gohring I; Devriendt K; de Ravel T; Bijlsma EK; Hennekam RC; Orrico A; Cohen M; Dreweke A; Reis A; Nurnberg P; Rauch A
    Am J Hum Genet; 2007 May; 80(5):994-1001. PubMed ID: 17436255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome.
    Kalscheuer VM; Feenstra I; Van Ravenswaaij-Arts CM; Smeets DF; Menzel C; Ullmann R; Musante L; Ropers HH
    Am J Med Genet A; 2008 Aug; 146A(16):2053-9. PubMed ID: 18627065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4.
    Brockschmidt A; Todt U; Ryu S; Hoischen A; Landwehr C; Birnbaum S; Frenck W; Radlwimmer B; Lichter P; Engels H; Driever W; Kubisch C; Weber RG
    Hum Mol Genet; 2007 Jun; 16(12):1488-94. PubMed ID: 17478476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Pitt-Hopkins syndrome with absence of hyperventilation.
    Inati A; Abbas HA; Korjian S; Daaboul Y; Harajeily M; Saab R
    J Child Neurol; 2013 Dec; 28(12):1698-701. PubMed ID: 23248353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations.
    Rosenfeld JA; Leppig K; Ballif BC; Thiese H; Erdie-Lalena C; Bawle E; Sastry S; Spence JE; Bandholz A; Surti U; Zonana J; Keller K; Meschino W; Bejjani BA; Torchia BS; Shaffer LG
    Genet Med; 2009 Nov; 11(11):797-805. PubMed ID: 19938247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum.
    Whalen S; Héron D; Gaillon T; Moldovan O; Rossi M; Devillard F; Giuliano F; Soares G; Mathieu-Dramard M; Afenjar A; Charles P; Mignot C; Burglen L; Van Maldergem L; Piard J; Aftimos S; Mancini G; Dias P; Philip N; Goldenberg A; Le Merrer M; Rio M; Josifova D; Van Hagen JM; Lacombe D; Edery P; Dupuis-Girod S; Putoux A; Sanlaville D; Fischer R; Drévillon L; Briand-Suleau A; Metay C; Goossens M; Amiel J; Jacquette A; Giurgea I
    Hum Mutat; 2012 Jan; 33(1):64-72. PubMed ID: 22045651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitt-Hopkins syndrome: report of a case with a TCF4 gene mutation.
    Taddeucci G; Bonuccelli A; Mantellassi I; Orsini A; Tarantino E
    Ital J Pediatr; 2010 Feb; 36():12. PubMed ID: 20205897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
    Sepp M; Pruunsild P; Timmusk T
    Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
    Sparber P; Filatova A; Anisimova I; Markova T; Voinova V; Chuhrova A; Tabakov V; Skoblov M
    Eur J Med Genet; 2020 Dec; 63(12):104088. PubMed ID: 33069932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction.
    Amiel J; Rio M; de Pontual L; Redon R; Malan V; Boddaert N; Plouin P; Carter NP; Lyonnet S; Munnich A; Colleaux L
    Am J Hum Genet; 2007 May; 80(5):988-93. PubMed ID: 17436254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.
    Marangi G; Ricciardi S; Orteschi D; Lattante S; Murdolo M; Dallapiccola B; Biscione C; Lecce R; Chiurazzi P; Romano C; Greco D; Pettinato R; Sorge G; Pantaleoni C; Alfei E; Toldo I; Magnani C; Bonanni P; Martinez F; Serra G; Battaglia D; Lettori D; Vasco G; Baroncini A; Daolio C; Zollino M
    Am J Med Genet A; 2011 Jul; 155A(7):1536-45. PubMed ID: 21671391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF4 deletions in Pitt-Hopkins Syndrome.
    Giurgea I; Missirian C; Cacciagli P; Whalen S; Fredriksen T; Gaillon T; Rankin J; Mathieu-Dramard M; Morin G; Martin-Coignard D; Dubourg C; Chabrol B; Arfi J; Giuliano F; Claude Lambert J; Philip N; Sarda P; Villard L; Goossens M; Moncla A
    Hum Mutat; 2008 Nov; 29(11):E242-51. PubMed ID: 18781613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal pads as a clue to the diagnosis of Pitt-Hopkins syndrome.
    Lehalle D; Williams C; Siu VM; Clayton-Smith J
    Am J Med Genet A; 2011 Jul; 155A(7):1685-9. PubMed ID: 21671383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic analysis of a rare case of Pitt-Hopkins syndrome due to partial deletion of TCF4 gene].
    Shen X; Qi F; Gu C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):459-461. PubMed ID: 32219837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
    Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
    Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
    Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
    Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
    Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
    Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
    Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
    J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaic 18q21.2 deletions including the TCF4 gene: a clinical report.
    Rossi M; Labalme A; Cordier MP; Till M; Blanchard G; Dubois R; Guibaud L; Heissat S; Javouhey E; Lachaux A; Mure PY; Ville D; Edery P; Sanlaville D
    Am J Med Genet A; 2012 Dec; 158A(12):3174-81. PubMed ID: 23165966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability.
    Maduro V; Pusey BN; Cherukuri PF; Atkins P; du Souich C; Rupps R; Limbos M; Adams DR; Bhatt SS; Eydoux P; Links AE; Lehman A; Malicdan MC; Mason CE; Morimoto M; Mullikin JC; Sear A; Van Karnebeek C; Stankiewicz P; Gahl WA; Toro C; Boerkoel CF
    Orphanet J Rare Dis; 2016 May; 11(1):62. PubMed ID: 27179618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.